The Pharma & MedTech industry is one of the most dynamic in the world. Expected to grow at nearly six percent annually over the next few years, change in the industry is fast becoming the norm. With constant change comes opportunity to progress, however women are still heavily unrepresented at a senior level, despite accounting for 60% of the overall workforce.
The Advancing Women’s Leadership in Pharma & MedTech Summit will help you overcome barriers to success faced by women. Learn how to navigate a successful career in a turbulent industry, stand out for opportunities, develop key leadership skills, make your value more visible and overcome various career obstacles.
Benefits of attending
- Build better relationships to underpin your career
- Manage through change associated with market globalisation & technological developments
- Transition from a technical specialist to a generalist leader
- Create your own opportunities to foster career success
- Develop a work/life balance that works for you
Who will attend?
Current and aspiring female leaders from Pharma, MedTech and Medical Devices, with roles and responsibilities for:
- Heads of Division
- Regional/National Manager
- Senior Management
- Clinical Operations/Scientific Manager
- Laboratory/Research Manager
- Sales and Account Management
- Team Leader
Attend to learn:
- Stand out for leadership opportunities
- Lead in an industry experiencing rapid & disruptive change
- Overcome obstacles & seize opportunities for career growth
- Be an impactful & authentic leader
Maurice Ben-Mayor has more than 20 years of experience in the Medical Technology sector. He is president for Stryker SouthPacific, a position he has held since 2015. Prior to this, Maurice spent seven years serving in a number of director roles within Stryker’s sales and marketing divisions. Maurice originally joined Stryker as a marketing manager in 2003. Prior to Stryker, Maurice worked as a sales representative for medical devices company, Synthes.
Maurice is passionate about innovative technology, developing people and building high-performing cultures. Maurice holds a Bachelor of Science (Psychology) and an MBA, both from The University of New South Wales. He is also a current board member of the Medical Technology Association of Australia.
Melinda Munns joined the pharmaceutical industry over 20 years ago after completing a PhD in Pharmacology in Melbourne Australia and a Post Doctorate Research Fellowship in London. Melinda worked at the Global Headquarters of Ipsen in London as a manager in their global clinical research program after which she took the opportunity to assist with the opening of the Australian subsidiary, leading clinical and medical projects. This led to a total tenure of 11 years with Ipsen. Subsequently, she joined Sanofi to manage an MSL team across 5 therapeutic areas. Melinda then took an unusual step to extend her managerial and operational skills by taking a role as a GM for an IT start-up company followed by a role as Global COO for a HR software company. During this time she completed her MBA. The need to make a difference for patients, led her back to pharma where she has thoroughly enjoyed the role as Associate Medical Director, Integrated Oncology followed by a promotion to Medical Director, Australia and New Zealand at Bristol-Myers Squibb.
Johnson & Johnson
Johnson & Johnson
With 20-years of experience in Orthopaedic Medical Devices, Kim Prendergast currently leads the Johnson & Johnson DePuy Synthes Joint Reconstruction Business Unit in Australia.
With skills spanning across sales and marketing and Bachelor of Arts (Communication) from Griffith University, Kim has been the strategic lead on a number of commercialisation, acquisition and integration projects.
Her extensive relationships in the medical device industry combined with technical experience and communications skills, enable Kim to take a collaborative approach to creating, planning and implementing opportunities for growth.
Having progressed into leadership from within a traditionally male dominated sector, Kim is a strong proponent that recognising, welcoming and cultivating the unique strengths of individuals is our most valuable competitive advantage.